BRAF and KRAS mutations in prostatic adenocarcinoma
Open Access
- 23 May 2006
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 119 (8), 1858-1862
- https://doi.org/10.1002/ijc.22071
Abstract
Constitutive activation of the kinase cascade involving RAS, RAF, MEK and ERK is common to human cancers, and mutations of KRAS and BRAF are mutually exclusive and serve as alternatives to activate the RAS/RAF/ERK signaling pathway. RAS mutations are known to occur in prostate adenocarcinomas, but little is known about BRAF mutations in these tumors. In the present study, BRAF and KRAS mutations were characterized in 206 prostate adenocarcinomas by enhanced PCR-RFLP and direct sequencing. The identified KRAS and BRAF mutations were then analyzed with respect to preoperative serum PSA levels, Gleason scores and tumor stages. Mutations in codon 600 of BRAF were identified in 21 (10.2%) of 206 prostate adenocarcinomas. KRAS mutations in codons 12 or 13 were found in 15 (7.3%) of 206 prostate adenocarcinomas. However, no tumor specimen contained both BRAF and KRAS mutations. Prostate adenocarcinomas with a BRAF mutation tended to show higher preoperative serum PSA levels, Gleason scores and tumor stages than prostate adenocarcinomas with a KRAS mutation. The results obtained show that BRAF mutations are as uncommon as KRAS mutations in prostate adenocarcinoma. Although BRAF and KRAS are members of the same RAS/ERK signaling pathway, prostate adenocarcinomas with a BRAF mutation showed clinicopathologic features that differed from those of prostate adenocarcinoma with a KRAS mutation.Keywords
This publication has 21 references indexed in Scilit:
- Relationship between genetic alterations and prognosis in sporadic colorectal cancerInternational Journal of Cancer, 2005
- Evaluation of a Large, Population-Based Sample Supports a CpG Island Methylator Phenotype in Colon CancerGastroenterology, 2005
- Poor Survival Associated with the BRAF V600E Mutation in Microsatellite-Stable Colon CancersCancer Research, 2005
- Cancer Statistics, 2005CA: A Cancer Journal for Clinicians, 2005
- Colorectal Cancer With Mutation in BRAF, KRAS, and Wild-Type With Respect to Both Oncogenes Showing Different Patterns of DNA MethylationJournal of Clinical Oncology, 2004
- BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectumGut, 2004
- Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAFCell, 2004
- RAF/RAS oncogenes and mismatch-repair statusNature, 2002
- DNA Hypermethylation Status of Multiple Genes in Prostate AdenocarcinomasJapanese Journal of Cancer Research, 2002
- Mutations of the BRAF gene in human cancerNature, 2002